Pediatric Clinical Trials Market - Industry Analysis, Size, Share, Growth, Trends and Forecast to 2025

PEDIATRIC CLINICAL TRIALS
MARKET
Global Industry Insights, Outlook Size, Share and
Opportunity Analysis, 2017–2025
© Coherent market Insights. All Rights Reserved
REPORT DESCRIPTION
Pediatric Clinical Trials Market Overview
The clinical trials conducted on children’s for the research and development of drugs or
formation of new drugs are called as pediatric clinical trials. Most of clinical trials are conducted
on adults and in very rare clinical trials children’s are included. To raise the involvement of
children’s into clinical trials the U.S. developed a regulatory and health strategy which focuses
on overall market of drugs when pediatric clinical trials are included. According to the data of
The World Bank Group, around 26% population out of the total world’s population includes
pediatrics (children’s between the age group 0-14), instead of this the clinical trials conducted
on adults are 10 times more than that of pediatrics because lack of infrastructure for pediatric
clinical trials, ethical issues, also pediatric disease are relatively low than disease found in adults
therefore the pharmaceutical companies focuses more on drug development for adults.
Request Sample Copy of the Business Report:
https://www.coherentmarketinsights.com/insight/request-sample/397
However, in past few years the pediatric clinical trials have raised because the increasing need of
pediatric medication also, due to increased understanding about the difference between the
drugs for adults and for children’s. The awareness about the pediatrics drugs are already more
in developed countries but in recent years it is increased massively in emerging nations also.
Which created the broad consumer platform for pharmaceutical companies. As per the stats of
U.S. Food and Drug Administration (U.S.FDA), as of February, 2017 total 935 pediatric study
request received out of that 505 request issued (This data is for the request received for all
types of drug study).
© Coherent market Insights. All Rights Reserved
REPORT DESCRIPTION
Pediatric clinical trials market taxonomy:
Global Market by Phase of Clinical Trial
• Pre-Clinical
• Phase I
• Phase II
• Phase III
Global Market by Study Design
• Sequential Design
• Adaptive Design
• Bayesian Design
• Randomized Withdrawal Design
• Randomized Placebo-Phase Design (Rppd)
• Three–Stage Clinical Trial Design
Request a Customization:
https://www.coherentmarketinsights.com/insight/request-customization/397
© Coherent market Insights. All Rights Reserved
REPORT DESCRIPTION
In pediatric clinical trials market, the North America is remained largest market share holding
region followed by Europe and APAC. As per the study published by The Office of Pediatric
Therapeutics (OPT), U.S. involved in around 86% pediatric clinical trials out of 346 clinical trials.
While most of clinical trials are conducted in U.S. but the trend is changing now, like as per the
data published by Future Medicine Ltd. in 2013, percentage of clinical pediatric studies
conducted is highest in China followed by Russia and India.
Get Exclusive Discount on this CMI Report:
https://www.coherentmarketinsights.com/insight/request-discount/397
The driving factors of pediatric clinical trials market are legislative mandatory changes leading
to the growth of pediatric clinical trials. As per the data of FDA, number of pediatric clinical
trials conducted in last five years is more than the combined pediatric clinical trials conducted
in last 30 years. Also, increased awareness about pediatrics drugs in emerging countries, more
research and development in this area, increased disease rate in infants, increased burden of
disease like diabetes in children’s and increasing involvement of contract research
organizations (CRO’s) in pediatric clinical trials are the leading factors in the growth of
pediatric clinical trials market.
Some are the companies and research institutes involved in pediatric clinical trials are
Genentech Inc., Children’s National Health System, INC Research etc.
© Coherent market Insights. All Rights Reserved
ABOUT COHERENT MARKET INSIGHTS
ABOUT US
Coherent Market Insights is a global market intelligence and consulting organization focused on
assisting its plethora of clients achieve transformational growth by helping them make critical business
decisions. We are headquartered in India, with an office at the global financial capital in the U.S. Our
client base includes players from across all business verticals in over 150 countries worldwide. We are
uniquely positioned to help businesses around the globe deliver practical and lasting results through
various recommendations about operational improvements, technologies, emerging market trends and
new working methods. We offer both customized and syndicated market research reports that help our
clients create visionary growth plans to provide traction to their business. We meticulously study
emerging trends across various industries at both the global and regional levels to identify new
opportunities for our clientele.
SERVICES
INDUSTRY ANALYSIS
CUSTOMIZED
RESEARCH
SYNDICATED RESEARCH
MARKET INTELLIGENCE
SERVICES
CONSULT STUDIES
COUNTRY SPECIFIC
STUDIES
© Coherent market Insights. All Rights Reserved
ABOUT CMI
SECTOR COVERAGE
BIOTECHNOLOGY
CLINICAL DIAGNOSTIC
HEALTHCARE IT
MEDICAL DEVICES
MEDICAL IMAGING
PHARMACEUTICAL
OUR CLIENTS
 Global Leading Equipment and System Manufacturers  Marketing Consultancies and the Advertising Industry
 Component Providers and System Integrators
 Private and Government organization
 Distributors, Retailors and Value Added Resellers
 Outsourcing Companies
 Healthcare IT Solutions Developers
 Universities and Business Schools.
© Coherent market Insights. All Rights Reserved
KEY STATS
RESEARCH SOLUTIONS
100+
FEASIBILITY
STUDIES
Insights Published
Per Year
GLOBAL
REPORTS
150+
Consulting Projects
Till Date
COUNTRY
ANALYSIS
CONSULT
PROJECTS
125+
Clients Worldwide
Per Year
110+
SURVEY
RESEARCH
EXCEL
FORECAST
DATABASE
CUSTOMIZED
SOLUTIONS
COMPETITIVE
ASSESSMENT
TECHNOLOGY
SNIPPETS
Analysts and Contract
Consultants
Coherent Market Insights excels at offering unmatched actionable market intelligence across various industry verticals,
including chemicals, healthcare, and food & beverages, to name a few. We implement holistic market research methodology in
order to result in the best possible market research reports across various industries worldwide. Based on our unmatched
expertise across various industries—no matter how large or small, how complex or unique—we help our clients achieve better
outcomes with uniquely designed and highly customized solutions. Our coverage includes insights that help our clients ensure
sustained growth in developed markets and also key inputs to help them tap into emerging markets and exploit the plethora of
opportunities posed therein.
© Coherent market Insights. All Rights Reserved
THANK YOU
To know more about us, visit our website:
www.coherentmarketinsights.com
For sales queries or new topics email us on:
[email protected]
For other queries contact:
Mr. Shah
(Manager - Business Development)
Coherent Market Insights
[email protected]
+1-206-701-6702
© Coherent market Insights. All Rights Reserved

The clinical trials conducted on children’s for the research and development of drugs or formation of new drugs are called as pediatric clinical trials. Most of clinical trials are conducted on adults and in very rare clinical trials children’s are included. To raise the involvement of children’s into clinical trials the U.S. developed a regulatory and health strategy which focuses on overall market of drugs when pediatric clinical trials are included. According to the data of The World Bank Group, around 26% population out of the total world’s population includes pediatrics (children’s between the age group 0-14), instead of this the clinical trials conducted on adults are 10 times more than that of pediatrics because lack of infrastructure for pediatric clinical trials, ethical issues, also pediatric disease are relatively low than disease found in adults therefore the pharmaceutical companies focuses more on drug development for adults.